Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis

Recently, two randomized trials, the PARTNER 3 and the Evolut Low Risk Trial, independently demonstrated that transcatheter aortic valve replacement (TAVR) is non-inferior to surgical aortic valve replacement (SAVR) for the treatment of severe aortic stenosis in patients at low surgical risk, paving...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Med
Huvudupphovsmän: Polimeni, Alberto, Sorrentino, Sabato, De Rosa, Salvatore, Spaccarotella, Carmen, Mongiardo, Annalisa, Sabatino, Jolanda, Indolfi, Ciro
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7074202/
https://ncbi.nlm.nih.gov/pubmed/32041189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9020439
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk